869 related articles for article (PubMed ID: 28095923)
1. NADPH oxidase in brain injury and neurodegenerative disorders.
Ma MW; Wang J; Zhang Q; Wang R; Dhandapani KM; Vadlamudi RK; Brann DW
Mol Neurodegener; 2017 Jan; 12(1):7. PubMed ID: 28095923
[TBL] [Abstract][Full Text] [Related]
2. The role of NOX inhibitors in neurodegenerative diseases.
Barua S; Kim JY; Yenari MA; Lee JE
IBRO Rep; 2019 Dec; 7():59-69. PubMed ID: 31463415
[TBL] [Abstract][Full Text] [Related]
3. The roles of NADPH oxidase and phospholipases A2 in oxidative and inflammatory responses in neurodegenerative diseases.
Sun GY; Horrocks LA; Farooqui AA
J Neurochem; 2007 Oct; 103(1):1-16. PubMed ID: 17561938
[TBL] [Abstract][Full Text] [Related]
4. Thioredoxin-Interacting Protein (TXNIP) in Cerebrovascular and Neurodegenerative Diseases: Regulation and Implication.
Nasoohi S; Ismael S; Ishrat T
Mol Neurobiol; 2018 Oct; 55(10):7900-7920. PubMed ID: 29488135
[TBL] [Abstract][Full Text] [Related]
5. The Role of NADPH Oxidases and Oxidative Stress in Neurodegenerative Disorders.
Tarafdar A; Pula G
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30513656
[TBL] [Abstract][Full Text] [Related]
6. Role of superoxide dismutases in oxidative damage and neurodegenerative disorders.
Maier CM; Chan PH
Neuroscientist; 2002 Aug; 8(4):323-34. PubMed ID: 12194501
[TBL] [Abstract][Full Text] [Related]
7. Role of NADPH oxidase isoforms NOX1, NOX2 and NOX4 in myocardial ischemia/reperfusion injury.
Braunersreuther V; Montecucco F; Asrih M; Pelli G; Galan K; Frias M; Burger F; Quinderé AL; Montessuit C; Krause KH; Mach F; Jaquet V
J Mol Cell Cardiol; 2013 Nov; 64():99-107. PubMed ID: 24051369
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
9. The effect of NADPH-oxidase inhibitor apocynin on cognitive impairment induced by moderate lateral fluid percussion injury: role of inflammatory and oxidative brain damage.
Ferreira AP; Rodrigues FS; Della-Pace ID; Mota BC; Oliveira SM; Velho Gewehr Cde C; Bobinski F; de Oliveira CV; Brum JS; Oliveira MS; Furian AF; de Barros CS; Ferreira J; Santos AR; Fighera MR; Royes LF
Neurochem Int; 2013 Nov; 63(6):583-93. PubMed ID: 24076474
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes.
Calabrese V; Boyd-Kimball D; Scapagnini G; Butterfield DA
In Vivo; 2004; 18(3):245-67. PubMed ID: 15341181
[TBL] [Abstract][Full Text] [Related]
11. Oral phycocyanobilin may diminish the pathogenicity of activated brain microglia in neurodegenerative disorders.
McCarty MF; Barroso-Aranda J; Contreras F
Med Hypotheses; 2010 Mar; 74(3):601-5. PubMed ID: 19576698
[TBL] [Abstract][Full Text] [Related]
12. Traumatic brain injury and NADPH oxidase: a deep relationship.
Angeloni C; Prata C; Dalla Sega FV; Piperno R; Hrelia S
Oxid Med Cell Longev; 2015; 2015():370312. PubMed ID: 25918580
[TBL] [Abstract][Full Text] [Related]
13. NADPH oxidase inhibition improves neurological outcome in experimental traumatic brain injury.
Lu XY; Wang HD; Xu JG; Ding K; Li T
Neurochem Int; 2014 Apr; 69():14-9. PubMed ID: 24589771
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of nicotinamide adenine dinucleotide phosphate-oxidase mediated stress reduces cell death after blast-induced traumatic brain injury.
Lucke-Wold BP; Naser ZJ; Logsdon AF; Turner RC; Smith KE; Robson MJ; Bailes JE; Lee JM; Rosen CL; Huber JD
Transl Res; 2015 Dec; 166(6):509-528.e1. PubMed ID: 26414010
[TBL] [Abstract][Full Text] [Related]
15. NADPH oxidase inhibition improves neurological outcomes in surgically-induced brain injury.
Lo W; Bravo T; Jadhav V; Titova E; Zhang JH; Tang J
Neurosci Lett; 2007 Mar; 414(3):228-32. PubMed ID: 17317004
[TBL] [Abstract][Full Text] [Related]
16. Environmental-induced oxidative stress in neurodegenerative disorders and aging.
Migliore L; Coppedè F
Mutat Res; 2009 Mar; 674(1-2):73-84. PubMed ID: 18952194
[TBL] [Abstract][Full Text] [Related]
17. Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies.
Chen JF; Chern Y
Handb Exp Pharmacol; 2011; (200):267-310. PubMed ID: 20859800
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase.
Zhang W; Wang T; Qin L; Gao HM; Wilson B; Ali SF; Zhang W; Hong JS; Liu B
FASEB J; 2004 Mar; 18(3):589-91. PubMed ID: 14734632
[TBL] [Abstract][Full Text] [Related]
19. Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: A literature review.
Bansal R; Singh R
Med Res Rev; 2018 Jul; 38(4):1126-1158. PubMed ID: 28697282
[TBL] [Abstract][Full Text] [Related]
20. Role of apolipoprotein E polymorphism as a prognostic marker in traumatic brain injury and neurodegenerative disease: a critical review.
Maiti TK; Konar S; Bir S; Kalakoti P; Bollam P; Nanda A
Neurosurg Focus; 2015 Nov; 39(5):E3. PubMed ID: 26646927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
